Carregant...
Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies
More than a century after its first description, Langerhans cell histiocytosis (LCH) still remains an intriguing disease. Considerable progress in understanding its biology has been achieved recently. Description of the V600E BRAF mutation in samples of LCH tissue in 2010 was followed by description...
Guardat en:
| Publicat a: | Immunotargets Ther |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066850/ https://ncbi.nlm.nih.gov/pubmed/27785447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S91058 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|